期刊文献+

Hypertrophic Cardiomyopathy as a Manifestation of Multiple Myeloma

Hypertrophic Cardiomyopathy as a Manifestation of Multiple Myeloma
下载PDF
导出
摘要 Multiple myeloma (MM) is a malignancy of the plasma cell characterized by migration and localization to the bone marrow where cells then disseminate and facilitate the formation of bone lesions. It is associated with a constellation of disease manifestations, apart from osteolytic lesions, anemia and immuno-suppression due to loss of normal hematopoietic stem cell function, and cardiac amyloidosis due to monoclonal immunoglobulin secretion as well. Amyloid infiltration of the heart may frequently masquerade as hypertrophic cardiomyopathy (HCM). HCM, of which underlying cause and pathogenesis are largely unknown, is characterized by left and/or right ventricular hypertrophy, with predominant involvement of the interventricular septum in the absence of other causes of hypertrophy, such as hypertension or valvular heart diseases. While excessive hypertrophy of the myocardium is most commonly associated with myocyte hypertrophy, infiltration with amyloid always needs to be considered. In this report we presented two cases of multiple myeloma that mimicked hypertrophic cardiomyopathy so closely that it required bone marrow or endomyocardial biopsy to establish the diagnosis. Multiple myeloma (MM) is a malignancy of the plasma cell characterized by migration and localization to the bone marrow where cells then disseminate and facilitate the formation of bone lesions. It is associated with a constellation of disease manifestations, apart from osteolytic lesions, anemia and immuno-suppression due to loss of normal hematopoietic stem cell function, and cardiac amyloidosis due to monoclonal immunoglobulin secretion as well. Amyloid infiltration of the heart may frequently masquerade as hypertrophic cardiomyopathy (HCM). HCM, of which underlying cause and pathogenesis are largely unknown, is characterized by left and/or right ventricular hypertrophy, with predominant involvement of the interventricular septum in the absence of other causes of hypertrophy, such as hypertension or valvular heart diseases. While excessive hypertrophy of the myocardium is most commonly associated with myocyte hypertrophy, infiltration with amyloid always needs to be considered. In this report we presented two cases of multiple myeloma that mimicked hypertrophic cardiomyopathy so closely that it required bone marrow or endomyocardial biopsy to establish the diagnosis.
出处 《South China Journal of Cardiology》 CAS 2008年第2期95-99,共5页 岭南心血管病杂志(英文版)
关键词 hypertrophic cardiomyopathy multiple myeloma hypertrophic cardiomyopathy multiple myeloma
  • 相关文献

参考文献9

  • 1Barlogie B,Shaughnessy J,Munshi N, et al.Plasma cell mye- loma. Williams Hematology[]..2001
  • 2Jemal A,Murray T,Ward E, et al.Cancer statistics,2005[].CA A Cancer Journal for Clinicians.2005
  • 3PEI DS.Clinical manifestations out of bone marrow about multi- ple myeloma[].Chinese practical medical journal.2003
  • 4Mitchell MA,Horneffer MD,Standiford TJ.Multiple myeloma complicated by restrictive cardiomyopathy and cardiac tampon- ade[].Chest.1993
  • 5Fuster V,Alexander RW,Robert AO,Rourke,HURST S.THE HEART[]..2002
  • 6Maron BJ.Hypertrophic Cardiomyopathy: A systematic Review[].The Journal of The American Medical Association.2002
  • 7Harousseau JL,,Shaughnessy J Jr,Richardson P.Multiple mye- loma[].Hematol Am Soc Hematol Educ Program.2004
  • 8MOTOYUKI N,MAMORU S,SHUGO K,et al.Reversible restrictive cardiomyopathy due to light - chain deposition disease[].Mayo Clinic Proceedings.2002
  • 9Roberts R,Sigwart U.Current Concepts of the Pathogenesis and Treat-ment of Hypertrophic Cardiomyopathy[].Circulation.2005

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部